Ferri C, De Mattia G, Piccoli A, Carlomagno A, Luparini R L, Germanò G, Giarrizzo C, Torregrossa G, Santucci A, Balsano F
University of Rome La Sapienza, Institute of I Clinica Medica, Andrea Cesalpino Foundation, Rome, Italy.
Am J Hypertens. 1991 Nov;4(11):880-4. doi: 10.1093/ajh/4.11.880.
In order to evaluate the effects of atrial natriuretic factor (ANF) infusion on plasma insulin (IRI) in hypertension, 32 essential hypertensives (aged 40 to 62 years) were studied. After 1 week of pharmacologic washout under normal sodium intake (120 mEq of Na+/day), patients were randomly assigned to receive either ANF (0.04 micrograms/kg/min) or its vehicle (50 mL of isotonic saline) over a 60-min period in supine position. Plasma IRI and glucose were measured at -60, 0, 20, 40, 60, 120, 180, and 240 min (infusion time: from 0 to 60 min). Plasma levels of IRI and glucose did not change significantly during ANF infusion. On the contrary, after ANF discontinuation plasma IRI rose from levels of 13.5 +/- 6.4 microU/mL at 60 min to values of 20.1 +/- 11.3 microU/mL at 240 min (P less than .0001 v time 0). Plasma glucose showed a similar behavior, increasing from values of 100.4 +/- 5.0 mg/dL at 60 min to values of 120.0 +/- 5.1 mg/dL at 240 min (P less than .02 v time 0). Our findings suggest that ANF did not influence insulin release in hypertensives. The increase of plasma glucose and IRI observed after ANF discontinuation could be due to the relapse of sympathetic activity, suppressed during ANF infusion.
为了评估心房利钠因子(ANF)输注对高血压患者血浆胰岛素(IRI)的影响,对32例原发性高血压患者(年龄40至62岁)进行了研究。在正常钠摄入(120 mEq Na⁺/天)下进行1周的药物洗脱后,患者仰卧位在60分钟内随机接受ANF(0.04微克/千克/分钟)或其溶媒(50毫升等渗盐水)。在-60、0、20、40、60、120、180和240分钟(输注时间:从0至60分钟)测量血浆IRI和葡萄糖。在ANF输注期间,血浆IRI和葡萄糖水平没有显著变化。相反,停用ANF后,血浆IRI从60分钟时的13.5±6.4微单位/毫升升至240分钟时的20.1±11.3微单位/毫升(与0分钟时相比,P<0.0001)。血浆葡萄糖表现出类似的变化,从60分钟时的100.4±5.0毫克/分升降至240分钟时的120.0±5.1毫克/分升(与0分钟时相比,P<0.02)。我们的研究结果表明,ANF对高血压患者的胰岛素释放没有影响。停用ANF后观察到的血浆葡萄糖和IRI升高可能是由于在ANF输注期间被抑制的交感神经活动的复发。